Antonio Rueda Martin

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Recent advances in high-throughput sequencing technologies have made ex-ome sequencing to be an outstanding tool for finding disease associated mutations at a relatively low cost. However, it is a non-trivial task to transform the vast amount of sequence data into meaningful variants to improve disease understanding. Several challenges arise when dealing(More)
  • 1